$5.93 1.2%
ANGO Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Angiodynamic

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.

Price $5.93
Target Price Sign up
Volume 18,200
Market Cap $240M
Year Range $5.27 - $8.04
Dividend Yield 0%
PE Ratio 41.4
Revenue per Employee $426,518
Earnings Date July 16 '24
Industry Medical & Dental Instruments

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2476M247M36M-188M-193M-0.160
Q4 '2380M77M40M-29M-6.5M-0.050
Q3 '2379M84M40M46M41M-0.120
Q2 '2390M103M46M-21M-13M0.020
Q1 '2380M79M41M-9.5M-1.1M-0.030

Insider Transactions View All

Clemmer James C filed to buy 539,066 shares at $6.7.
April 8 '24
Helsel Dave filed to sell 19,189 shares at $13.
February 1 '23
Trowbridge Stephen A filed to buy 89,581 shares at $13.8.
October 12 '22
Clemmer James C filed to buy 450,407 shares at $15.
October 11 '22
Helsel Dave filed to sell 23,822 shares at $22.4.
August 1 '22

What is the Market Cap of Angiodynamic?

The Market Cap of Angiodynamic is $240M.

What is Angiodynamic's PE Ratio?

As of today, Angiodynamic's PE (Price to Earnings) ratio is 41.4.

How Many People Work at Angiodynamic?

As of our latest update, Angiodynamic employed approximately 760 people worldwide. However, it's important to note that Angiodynamic's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Angiodynamic's revenue per employee?

$426,518. To calculate Angiodynamic's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Angiodynamic report earnings?

Angiodynamic will report its next earnings on July 16 '24.

What is the current stock price of Angiodynamic?

Currently, the price of one share of Angiodynamic stock is $5.93.

How can I analyze the ANGO stock price chart for investment decisions?

The ANGO stock price chart above provides a comprehensive visual representation of Angiodynamic's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Angiodynamic shares. Our platform offers an up-to-date ANGO stock price chart, along with technical data analysis and alternative data insights.

Does ANGO offer dividends to its shareholders?

As of our latest update, Angiodynamic (ANGO) does not offer dividends to its shareholders. Investors interested in Angiodynamic should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Angiodynamic?

Some of the similar stocks of Angiodynamic are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.